Point of Care D-Dimer Testing in the Emergency Department: A Bioequivalence Study

نویسندگان

  • Shuhana Perveen
  • Danielle Unwin
  • Amith Loknath Shetty
چکیده

BACKGROUND D-dimer is used widely as a diagnostic aid in low- and moderate-risk patients with suspected venous thromboembolism (VTE). While our laboratory utilizes VIDAS D-dimer analyzer (bioMérieux SA, France), our emergency department (ED) recently procured a D-dimer analyzer AQT90 FLEX (Radiometer Medical ApS, Denmark) for point of care testing (POCT) to facilitate patient management. We aimed to determine whether the time taken to receive D-dimer results using the 2 different analyzers differed significantly and to quantify the limits of agreement between the results of the 2 methods measured on the same patient. METHODS Adult patients presenting to the ED and requiring diagnostic workup for suspected VTE were included in this prospective observational study. Patients underwent simultaneous D-dimer measurements using the 2 different analyzers. RESULTS The paired results from 104 patients were analyzed. The median time for the D-dimer results from triage by VIDAS was 258 min (Inter-quartile range [IQR], 173-360) and by POCT was 146 min (IQR, 55-280.5); the median time difference was 101.5 min (IQR, 82-125.5). On an average, POCT D-dimer values were 15% lower on the same sample (limits of agreement, 34-213%). POCT predicted 83% of VIDAS positive results (sensitivity, 83.3% [95% confidence interval (CI), 70.4-91.3%]; specificity, 100% [95% CI, 93.6-100%]). All patients with positive imaging were identified correctly by both methods. CONCLUSIONS POCT delivers D-dimer results in significantly shorter turnaround times than pathology services; however, poor bioequivalence between VIDAS and POCT raises the issue of acceptability for use in the ED.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Response to the Comments on 'Point of Care D-Dimer Testing in the Emergency Department-A Bioequivalence Study' and Erratum to the Results

We have read with interest the comments made on our study titled ‘Point of care (POC) D-dimer testing in the Emergency department–a bioequivalence study’ [1]. Ekelund and Heilmann, referring to the results and conclusions of the study, have suggested that one of the discrepancies may be caused by a typographical error, and this inference probably stems from the use of the term ‘range’ in the pu...

متن کامل

Evaluation of Correlation between D-dimer Levels with Disease Severity in Patients with Covid-19 Referred to Hamedan Besat Hospital in 2021-2022

Introduction: The Covid-19 virus affects the hemostasis system in infected people by causing thrombosis and it increases the level of D_dimer. This study was designed and conducted for the evaluation of correlation between D-dimer levels with disease severity in patients with Covid-19 referred to Hamedan Besat hospital. Methods and Materials: 366 patients with Covid-19 referred to Besat Hospit...

متن کامل

Comments on Point of Care D-Dimer Testing in the Emergency Department: A Bioequivalence Study

Dear Editor We read with interest the article “Point of Care D-Dimer Testing in the Emergency Department: A Bioequivalence Study” by Perveen et al. published in Ann Lab Med 2013;33:34-38 [1]. In this article, the authors compared the performance of the D-dimer assays on the AQT90 FLEX analyzer (Radiometer Medical Aps, Åkandevej, Denmark) and the VIDAS analyzer (bioMérieux SA, RCS Lyon, France)....

متن کامل

POCT is a true asset in the emergency department

Background To determine patient priority and degree of urgency with an objective high-quality evaluation, general Point of Care testing (POCT) was established as a novel facility in the Emergency department at Holbæk Hospital. The hardware consists of AQT-90 Flex (CRP, D-dimer), ABL-800 (Na, K, Hgb, BG etc.) and HemoCue (Leukocytes), thus rendering useful parameters within initial assessment. A...

متن کامل

Perspectives on cost and outcomes for point-of-care testing.

Point-of-care testing (POCT) is usually more expensive on a unit-cost basis than testing performed in a central laboratory. It is difficult to manage POCT and to maintain regulatory compliance, especially in large institutions. However, some POCT technologies have improved patient outcomes (patient self-glucose monitoring in the home, tight glycemic control in intensive care settings) or hospit...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 33  شماره 

صفحات  -

تاریخ انتشار 2013